Why is Cystic Fibrosis Called a Genetic Disorder?

1
Cystic Fibrosis - Pipeline Review, H1 2016
Telephone [phone]Mail at
sales_at_researchbeam.com
(Type, Mode of action, Crop Type and Geography) -
Size, Share, Global Trends, Company Profiles,
Demand, Insights, Analysis, Research, Report,
Opportunities, Segmentation and Forecast, 2013 -
2020
Published on Oct 2014
2


Report Overview

• Cystic Fibrosis - Pipeline Review, H1 2016,
  provides an overview of the Cystic Fibrosis
  pipeline landscape.
• The report provides comprehensive information on
  the therapeutics under development for Cystic
  Fibrosis, complete with analysis by stage of
  development, drug target, mechanism of action
  (MoA), route of administration (RoA) and molecule
  type. The report also covers the descriptive
  pharmacological action of the therapeutics, its
  complete research and development history and
  latest news and press releases. Additionally, the
  report provides an overview of key players
  involved in therapeutic development for Cystic
  Fibrosis and features dormant and discontinued
  projects.
• This report features investigational drugs from
  across globe covering over 20 therapy areas and
  nearly 3,000 indications. The report is built
  using data and information sourced from Global
  Markets Directs proprietary databases,
  company/university websites, clinical trial
  registries, conferences, SEC filings, investor
  presentations and featured press releases from
  company/university sites and industry-specific
  third party sources. Drug profiles featured in
  the report undergoes periodic review following a
  stringent set of processes to ensure that all the
  profiles are updated with the latest set of
  information. Additionally, various dynamic
  tracking processes ensure that the most recent
  developments are captured on a real time basis.
• The report helps in identifying and tracking
  emerging players in the market and their
  portfolios, enhances decision making capabilities
  and helps to create effective counter strategies
  to gain competitive advantage.
• Strategic Focus Report http//www.researchbeam.co
  m/cystic-fibrosis-pipeline-review-h1-2016-market

3


Report Overview

• Scope
• - The report provides a snapshot of the global
  therapeutic landscape of Cystic Fibrosis
• - The report reviews pipeline therapeutics for
  Cystic Fibrosis by companies and
  universities/research institutes based on
  information derived from company and
  industry-specific sources
• -The report covers pipeline products based on
  various stages of development ranging from
  pre-registration till discovery and undisclosed
  stages
• - The report features descriptive drug profiles
  for the pipeline products which includes, product
  description, descriptive MoA, RD brief,
  licensing and collaboration details other
  developmental activities
• Reasons to buy
• - Gain strategically significant competitor
  information, analysis, and insights to formulate
  effective RD strategies
• - Identify emerging players with potentially
  strong product portfolio and create effective
  counter-strategies to gain competitive advantage
• - Identify and understand important and diverse
  types of therapeutics under development for
  Cystic Fibrosis
• - Identify potential new clients or partners in
  the target demographic
• - Develop strategic initiatives by understanding
  the focus areas of leading companies

4


Table of Contents
Table of Contents 2 List of Tables 8 List of
Figures 10 Introduction 11 Global Markets Direct
Report Coverage 11 Cystic Fibrosis Overview
12 Therapeutics Development 13 Pipeline Products
for Cystic Fibrosis - Overview 13 Pipeline
Products for Cystic Fibrosis - Comparative
Analysis 14 Cystic Fibrosis - Therapeutics under
Development by Companies 15 Cystic Fibrosis -
Therapeutics under Investigation by
Universities/Institutes 21 Cystic Fibrosis -
Pipeline Products Glance 22 Late Stage Products
22 Clinical Stage Products 23 Early Stage
Products 24 Unknown Stage Products 25 Cystic
Fibrosis - Products under Development by
Companies 26 Cystic Fibrosis - Products under
Investigation by Universities/Institutes
34 Cystic Fibrosis - Companies Involved in
Therapeutics Development 35 Actelion Ltd 35 Akari
Therapeutics, Plc 36 Alaxia SAS 37 AlgiPharma AS
38
5


Report Ordering
Report Name Cystic Fibrosis -
Pipeline Review, H1 2016
Product Price
User Price
Single User US 1700
Site User US 4000
Global User US 6000
To View Sample or Purchase Report
6



Contact Us
FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/cystic-fibrosis-pipeli
ne-review-h1-2016-market
Stay With Us At
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone] DIRECT 1 (503)
894-6022E-MAIL sales_at_researchbeam.com